PATENT CLAIM ANALYSIS

Application Number: 16091699
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-09
Patent Classification: ["514", "456000"]

Abstract:
A method for providing isoflavonoid compounds to the central nervous system comprising the step of rectally administering the compound to an individual in need thereof. This method is useful in the treatment of brain cancers, including glioblastoma multiforme.

Claim (Index 4):
The method of  claim 1 , wherein the compound is selected from:

Metadata:
- Claim Count in Document: 22.0
- Percentile: 97.0
- Lexical Diversity: 1.24242
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15714647', '11909538', '15968462', '13907427', '11303854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75879886998897
- 35 USC 102 Novelty (BERT): 0.4763034571673431
- Combined Prediction Score: 0.7305493287068072
- Mean Citation Score: 174.40313799999996
- Max Citation Score: 178.48242
- Similarity Product: 136.2405889610231

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test